A citation-based method for searching scientific literature

Karin Leunen, Maria Drijkoningen, Patrick Neven, Maria-Rose Christiaens, Chantal Van Ongeval, Eric Legius, Frédéric Amant, Patrick Berteloot, Ignace Vergote. Breast Cancer Res Treat 2008
Times Cited: 7







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
N Hoogerbrugge, P Bult, L M de Widt-Levert, L V Beex, L A Kiemeney, M J L Ligtenberg, L F Massuger, C Boetes, P Manders, H G Brunner. J Clin Oncol 2003
77
85

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
Noah D Kauff, Edi Brogi, Lauren Scheuer, Dorothy R Pathak, Patrick I Borgen, Clifford A Hudis, Kenneth Offit, Mark E Robson. Cancer 2003
58
57

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
632
42

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Camilo Adem, Carol Reynolds, Cheryl L Soderberg, Jeffrey M Slezak, Shannon K McDonnell, Thomas J Sebo, Daniel J Schaid, Jeffrey L Myers, Thomas A Sellers, Lynn C Hartmann,[...]. Cancer 2003
57
42

Prophylactic mastectomy for the prevention of breast cancer.
L Lostumbo, N Carbine, J Wallace, J Ezzo. Cochrane Database Syst Rev 2004
98
28

Survival and prognostic factors in BRCA1-associated breast cancer.
C T M Brekelmans, C Seynaeve, M Menke-Pluymers, H T Brüggenwirth, M M A Tilanus-Linthorst, C C M Bartels, M Kriege, A N van Geel, C M G Crepin, J C Blom,[...]. Ann Oncol 2006
97
28

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
706
28

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
178
28

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
28

Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.
Kelly A Metcalfe, John L Semple, Steven A Narod. Plast Reconstr Surg 2004
58
28

Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer.
Brenda B J Hermsen, Silvia von Mensdorff-Pouilly, Hans F J Fabry, Hay A H Winters, Peter Kenemans, René H M Verheijen, Paul J van Diest. J Pathol 2005
17
28

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002
586
28


High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
Banu Arun, Kristen J Vogel, Adriana Lopez, Mike Hernandez, Deann Atchley, Kristine R Broglio, Christopher I Amos, Funda Meric-Bernstam, Henry Kuerer, Gabriel N Hortobagyi,[...]. Cancer Prev Res (Phila) 2009
18
28

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
S K McDonnell, D J Schaid, J L Myers, C S Grant, J H Donohue, J E Woods, M H Frost, J L Johnson, D L Sitta, J M Slezak,[...]. J Clin Oncol 2001
190
14

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005
196
14

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
385
14

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
Kristi D Graves, Beth N Peshkin, Chanita H Halbert, Tiffani A DeMarco, Claudine Isaacs, Marc D Schwartz. Breast Cancer Res Treat 2007
43
14

Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer.
E Chabner, A Nixon, R Gelman, S Hetelekidis, A Recht, B Bornstein, J Connolly, S Schnitt, B Silver, J Manola,[...]. J Clin Oncol 1998
63
14

Contralateral breast cancer: annual incidence and risk parameters.
P Broët, A de la Rochefordière, S M Scholl, A Fourquet, V Mosseri, J C Durand, P Pouillart, B Asselain. J Clin Oncol 1995
140
14

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
459
14


Incidence and outcomes of contralateral breast cancers.
Glenda Quan, SuEllen J Pommier, Rodney F Pommier. Am J Surg 2008
48
14


Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, A vd Ouweland, M B E Menke-Pluymers, C C M Bartels, M Kriege, A N van Geel, C W Burger, A M M Eggermont,[...]. Eur J Cancer 2007
146
14

Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
Marlene H Frost, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan,[...]. J Clin Oncol 2005
137
14

Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
E A Peralta, J D Ellenhorn, L D Wagman, A Dagis, J S Andersen, D Z Chu. Am J Surg 2000
146
14

Reoperations after prophylactic mastectomy with or without implant reconstruction.
Sara M Zion, Jeffrey M Slezak, Thomas A Sellers, John E Woods, Phillip G Arnold, Paul M Petty, John H Donohue, Marlene H Frost, Daniel J Schaid, Lynn C Hartmann. Cancer 2003
52
14

Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
Katja Goldflam, Kelly K Hunt, Jeffrey E Gershenwald, S Eva Singletary, Nadeem Mirza, Henry M Kuerer, Gildy V Babiera, Frederick C Ames, Merrick I Ross, Barry W Feig,[...]. Cancer 2004
85
14

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Todd M Tuttle, Stephanie Jarosek, Elizabeth B Habermann, Amanda Arrington, Anasooya Abraham, Todd J Morris, Beth A Virnig. J Clin Oncol 2009
263
14

Selective use of sentinel lymph node surgery during prophylactic mastectomy.
Judy C Boughey, Nazanin Khakpour, Funda Meric-Bernstam, Merrick I Ross, Henry M Kuerer, Sonja E Singletary, Gildy V Babiera, Banu Arun, Kelly K Hunt, Isabelle Bedrosian. Cancer 2006
56
14

Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007.
Armando E Giuliano, Susan Boolbol, Amy Degnim, Henry Kuerer, A Marilyn Leitch, Monica Morrow. Ann Surg Oncol 2007
83
14

A reappraisal of prophylactic mastectomy.
I L Wapnir, B Rabinowitz, R S Greco. Surg Gynecol Obstet 1990
25
14

Familial indications for prophylactic surgery in breast-cancer-prone families.
H T Lynch, R E Harris, C H Organ, J F Lynch. Lancet 1978
5
20

Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy.
Christine Laronga, M Catherine Lee, Kandace P McGuire, Tammi Meade, W Bradford Carter, Susan Hoover, Charles E Cox. J Am Coll Surg 2009
18
14

The added value of molecular testing in small pancreatic cysts.
Adam D Toll, Thomas Kowalski, David Loren, Marluce Bibbo. JOP 2010
27
14

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.
Daniel H Kim, Beth Crawford, John Ziegler, Mary S Beattie. Fam Cancer 2009
28
14

Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.
Susan Miller-Samuel, Deborah J MacDonald, Jeffrey N Weitzel, Ferdy Santiago, Martin A Martino, Tara Namey, Annmarie Augustyn, Rebecca Mueller, Andrea Forman, Angela R Bradbury,[...]. Semin Oncol 2011
12
14

Clinical management of women at increased risk for breast cancer.
V G Vogel, A Yeomans, E Higginbotham. Breast Cancer Res Treat 1993
29
14

Early detection of pancreatic cancer: why, who, and how to screen.
Jason Klapman, Mokenge P Malafa. Cancer Control 2008
76
14

Total mastectomy: indications and techniques.
C E Horton, W H Dascombe. Clin Plast Surg 1988
9
14


Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Elizabeth C Verna, Caroline Hwang, Peter D Stevens, Heidrun Rotterdam, Stavros N Stavropoulos, Carolyn D Sy, Martin A Prince, Wendy K Chung, Robert L Fine, John A Chabot,[...]. Clin Cancer Res 2010
158
14

Prophylactic mastectomy in high risk patients: a practice-based review of the indications. Do we follow guidelines?
Derrick J Hoover, Prakash R Paragi, Elissa Santoro, Sarah Schafer, Ronald S Chamberlain. Breast Dis 2010
11
14

Prophylactic mastectomy.
L A Newman, H M Kuerer, K K Hung, G Vlastos, F C Ames, M I Ross, S E Singletary. J Am Coll Surg 2000
24
14

Absence of germline BRCA1 mutations in familial pancreatic cancer patients.
Jennifer E Axilbund, Pedram Argani, Mihoko Kamiyama, Emily Palmisano, Marian Raben, Michael Borges, Kieran A Brune, Michael Goggins, Ralph H Hruban, Alison P Klein. Cancer Biol Ther 2009
34
14

Indications for prophylactic mastectomy.
J R Nemecek, V L Young, M J Lopez. Mo Med 1993
9
14

Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
Shinichi Yachida, Siân Jones, Ivana Bozic, Tibor Antal, Rebecca Leary, Baojin Fu, Mihoko Kamiyama, Ralph H Hruban, James R Eshleman, Martin A Nowak,[...]. Nature 2010
14

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
David J Gallagher, Mia M Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal Vora, Jasmine Bhatia, Zsofia Stadler, Samson W Fine, Victor Reuter,[...]. Clin Cancer Res 2010
174
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.